{"title":"桂皮汤治疗贫血的系统评价及meta分析。","authors":"Xueyan Lv, Dongmei Wang, Xiangni Zou","doi":"10.1097/MD.0000000000043625","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anemia is a common and widely influential public health problem worldwide. The objective was to conduct a comprehensive and in-depth systematic evaluation of the therapeutic efficacy of Guipi Decoction as an adjuvant treatment for patients with anemia and to offer new ideas for the clinical treatment of anemia.</p><p><strong>Methods: </strong>A comprehensive and systematic literature search was meticulously executed across multiple authoritative databases, including CNKI, Wanfang, VIP, EMBase, Scopus, Web of Science, PubMed, and the Cochrane Library. The search was designed to identify all relevant randomized controlled trials that investigated the application of Guipi Decoction as an adjuvant therapy for Anemia patients. Considering that 1 researcher had written article of this kind in 2020, so the time frame of the search spanned from January 2020 to January 2025. Two independent reviewers selected eligible trials, extracted data, and assessed methodological quality using predefined criteria. Meta-analysis was performed using the standardized software RevMan 5.3.</p><p><strong>Results: </strong>A total of 13 studies were included in the final analysis, involving a cumulative sample size of 954 participants. These participants were randomly allocated to the experimental group and the control group. Pretreatment physiological parameters were comparable between the 2 groups, with no statistically significant differences, indicating a balanced randomization. Posttreatment, the experimental group demonstrated significantly better outcomes across multiple clinically relevant endpoints compared to the control group. The indicators include the effective rate, adverse event rate, hemoglobin, red blood cell, serum iron, serum ferritin, and hematocrit. For the experimental group, there are statistically significant differences in various indicators before and after treatment. At the same time, when compared with the indicators of the control group after treatment, the outcome indicators of the experimental group show a better therapeutic effect, and the differences are statistically significant. This can strongly prove that Guipi Decoction has a definite therapeutic effect on treating anemia.</p><p><strong>Conclusion: </strong>Guipi Decoction can effectively relieve symptoms in anemia patients and reduce risk indicators. It is worthy of further research and promotion.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":"104 30","pages":"e43625"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303479/pdf/","citationCount":"0","resultStr":"{\"title\":\"Systematic review and meta-analysis of Guipi Decoction in the treatment of anemia.\",\"authors\":\"Xueyan Lv, Dongmei Wang, Xiangni Zou\",\"doi\":\"10.1097/MD.0000000000043625\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Anemia is a common and widely influential public health problem worldwide. The objective was to conduct a comprehensive and in-depth systematic evaluation of the therapeutic efficacy of Guipi Decoction as an adjuvant treatment for patients with anemia and to offer new ideas for the clinical treatment of anemia.</p><p><strong>Methods: </strong>A comprehensive and systematic literature search was meticulously executed across multiple authoritative databases, including CNKI, Wanfang, VIP, EMBase, Scopus, Web of Science, PubMed, and the Cochrane Library. The search was designed to identify all relevant randomized controlled trials that investigated the application of Guipi Decoction as an adjuvant therapy for Anemia patients. Considering that 1 researcher had written article of this kind in 2020, so the time frame of the search spanned from January 2020 to January 2025. Two independent reviewers selected eligible trials, extracted data, and assessed methodological quality using predefined criteria. Meta-analysis was performed using the standardized software RevMan 5.3.</p><p><strong>Results: </strong>A total of 13 studies were included in the final analysis, involving a cumulative sample size of 954 participants. These participants were randomly allocated to the experimental group and the control group. Pretreatment physiological parameters were comparable between the 2 groups, with no statistically significant differences, indicating a balanced randomization. Posttreatment, the experimental group demonstrated significantly better outcomes across multiple clinically relevant endpoints compared to the control group. The indicators include the effective rate, adverse event rate, hemoglobin, red blood cell, serum iron, serum ferritin, and hematocrit. For the experimental group, there are statistically significant differences in various indicators before and after treatment. At the same time, when compared with the indicators of the control group after treatment, the outcome indicators of the experimental group show a better therapeutic effect, and the differences are statistically significant. This can strongly prove that Guipi Decoction has a definite therapeutic effect on treating anemia.</p><p><strong>Conclusion: </strong>Guipi Decoction can effectively relieve symptoms in anemia patients and reduce risk indicators. It is worthy of further research and promotion.</p>\",\"PeriodicalId\":18549,\"journal\":{\"name\":\"Medicine\",\"volume\":\"104 30\",\"pages\":\"e43625\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303479/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MD.0000000000043625\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000043625","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:贫血是世界范围内常见且影响广泛的公共卫生问题。目的是对桂皮汤辅助治疗贫血患者的疗效进行全面、深入的系统评价,为临床治疗贫血提供新的思路。方法:在CNKI、万方、VIP、EMBase、Scopus、Web of Science、PubMed、Cochrane Library等多个权威数据库进行全面系统的文献检索。本研究旨在确定所有研究桂皮汤辅助治疗贫血患者的相关随机对照试验。考虑到2020年有1位研究者写过这类文章,所以搜索的时间范围为2020年1月至2025年1月。两名独立的审稿人选择符合条件的试验,提取数据,并使用预定义的标准评估方法学质量。采用标准化软件RevMan 5.3进行meta分析。结果:最终分析共纳入13项研究,涉及954名参与者的累积样本量。这些参与者被随机分为实验组和对照组。两组间预处理生理参数具有可比性,差异无统计学意义,说明采用了平衡随机化。治疗后,与对照组相比,实验组在多个临床相关终点上表现出明显更好的结果。指标包括有效率、不良事件发生率、血红蛋白、红细胞、血清铁、血清铁蛋白、红细胞压积。实验组治疗前后各项指标差异均有统计学意义。同时,与对照组治疗后的各项指标比较,实验组的结局指标均表现出更好的治疗效果,差异有统计学意义。这有力地证明桂皮汤治疗贫血有一定的疗效。结论:桂皮汤能有效缓解贫血患者的症状,降低贫血患者的危险指标。值得进一步研究和推广。
Systematic review and meta-analysis of Guipi Decoction in the treatment of anemia.
Background: Anemia is a common and widely influential public health problem worldwide. The objective was to conduct a comprehensive and in-depth systematic evaluation of the therapeutic efficacy of Guipi Decoction as an adjuvant treatment for patients with anemia and to offer new ideas for the clinical treatment of anemia.
Methods: A comprehensive and systematic literature search was meticulously executed across multiple authoritative databases, including CNKI, Wanfang, VIP, EMBase, Scopus, Web of Science, PubMed, and the Cochrane Library. The search was designed to identify all relevant randomized controlled trials that investigated the application of Guipi Decoction as an adjuvant therapy for Anemia patients. Considering that 1 researcher had written article of this kind in 2020, so the time frame of the search spanned from January 2020 to January 2025. Two independent reviewers selected eligible trials, extracted data, and assessed methodological quality using predefined criteria. Meta-analysis was performed using the standardized software RevMan 5.3.
Results: A total of 13 studies were included in the final analysis, involving a cumulative sample size of 954 participants. These participants were randomly allocated to the experimental group and the control group. Pretreatment physiological parameters were comparable between the 2 groups, with no statistically significant differences, indicating a balanced randomization. Posttreatment, the experimental group demonstrated significantly better outcomes across multiple clinically relevant endpoints compared to the control group. The indicators include the effective rate, adverse event rate, hemoglobin, red blood cell, serum iron, serum ferritin, and hematocrit. For the experimental group, there are statistically significant differences in various indicators before and after treatment. At the same time, when compared with the indicators of the control group after treatment, the outcome indicators of the experimental group show a better therapeutic effect, and the differences are statistically significant. This can strongly prove that Guipi Decoction has a definite therapeutic effect on treating anemia.
Conclusion: Guipi Decoction can effectively relieve symptoms in anemia patients and reduce risk indicators. It is worthy of further research and promotion.
期刊介绍:
Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.